Yazılar

Google Integrates SandboxAQ’s Quantitative AI Models into Cloud Services

/in /tarafından

Google Cloud has expanded its offerings by integrating SandboxAQ’s large quantitative models (LQMs), designed to process complex numerical data and perform advanced statistical analysis. This move highlights the growing interest of cloud providers in AI technology as a key driver of future growth.

Key Points:

  • Partnership with SandboxAQ: Quantum startup SandboxAQ has announced that its LQMs will be available on Google Cloud, making it easier for businesses to use and deploy these models. SandboxAQ, a spin-off of Google-parent Alphabet, is seeking to expand its reach and customer base through this collaboration.
  • Capabilities of LQMs: The models are designed to handle large-scale datasets and perform intricate calculations, ideal for creating advanced financial models, automating trading strategies, and addressing complex business problems. These models are particularly useful in industries like life sciences, financial services, and navigation.
  • Quantum AI Synergy: According to SandboxAQ CEO Jack Hidary, quantitative AI is essential for many sectors of the economy, especially where mathematical and quantitative relationships are fundamental. He emphasized the complementary nature of quantitative AI and language models in solving complex challenges.
  • SandboxAQ’s Growth: In the previous month, SandboxAQ raised $300 million in funding, which boosted its valuation to $5.6 billion. The company is backed by prominent investors including Fred Alger Management, T. Rowe Price, and Breyer Capital.
  • Broader Industry Impacts: Google’s push into quantum computing, including progress on new quantum chips, is seen as part of its broader strategy to lead in this emerging field. Competitors such as Microsoft and Nvidia have also been active in exploring quantum computing, although practical applications are still seen as years away.

Dexcom Introduces AI-Powered Reports for Stelo Glucose Monitor, Offering Personalized Insights

/in /tarafından

Dexcom has launched a new artificial intelligence feature for its Stelo continuous glucose monitor (CGM), giving users a more personalized view of how their meals, sleep, and activities affect their glucose levels. This AI-driven addition, which debuted on Tuesday, is part of Dexcom’s broader efforts to enhance user engagement and provide deeper insights into glucose management.

Stelo, an over-the-counter CGM that monitors real-time blood sugar levels by inserting a small sensor under the skin, was first introduced in August. Unlike traditional CGMs, Stelo is designed for adults who do not take insulin, opening up a new consumer market for the company. This latest feature aims to make Stelo more valuable and personalized for everyday users, with Dexcom focusing on enhancing its capabilities for a broader audience.

Jake Leach, Dexcom’s chief operating officer, emphasized that user feedback had driven the company’s decision to integrate more advanced AI features. “The No. 1 feedback we get is users want to see more,” Leach explained in an interview with CNBC. “They’re making an investment and wearing the product, and they want to be able to take the most advantage of all the data that they’re generating.” The new AI-generated reports reflect this need for deeper, actionable insights.

Dexcom is leveraging Google Cloud’s Vertex AI platform and its Gemini models to build the new AI features. These tools enable developers to synthesize diverse data types, a complex task in healthcare. The company is proceeding cautiously, ensuring the AI platform adds value without compromising the reliability of its core CGM products, which are essential for managing serious health conditions.

While Stelo users have always had access to weekly insights reports, these reports were traditionally formatted in a standard template. The new AI-powered version promises to offer a more personalized experience, drawing on individual user data to provide tailored feedback. For example, if a user’s activity level is low after meals, the report will include specific recommendations to help improve glucose management.

It is important to note that while the AI feature offers personalized insights, it does not provide medical advice. Dexcom has developed the feature with guidance from the U.S. Food and Drug Administration’s (FDA) AI framework. The FDA approved Stelo for use in March, and the company is now looking at expanding the use of generative AI across its other CGM products.

Looking forward, Dexcom plans to evolve its AI capabilities to provide real-time feedback rather than just weekly summaries. The company also envisions using the AI platform to predict potential issues before they arise, much like a “check engine light” in a car, providing early warnings and suggestions for further consultation with healthcare providers.

Chris Sakalosky, vice president of strategic industries at Google Cloud, noted the potential for the technology to offer predictive insights. “It gives you a sense for what could be going on, and recommendations of where you might want to go to seek more advice,” Sakalosky said.

The updated AI-powered reports are already rolling out to Stelo users this week, marking an important step in Dexcom’s mission to make glucose monitoring more intuitive and informative for consumers.

 

Suki Expands Collaboration with Google Cloud to Enhance AI Tools for Clinicians

/in /tarafından

Health-tech startup Suki has announced an expanded partnership with Google Cloud, focusing on broadening its range of assistive tools for healthcare professionals. The collaboration leverages Google Cloud’s Vertex AI platform, which enables the development and deployment of advanced AI models. With this new integration, Suki aims to go beyond clinical documentation to offer tools that support clinicians in managing patient data more efficiently.

Suki’s flagship product, the Suki Assistant, helps physicians by automatically converting patient visit recordings into clinical notes, thus relieving them of the time-consuming task of manual documentation. The enhanced partnership with Google Cloud introduces two new features—patient summarization and a Q&A tool—designed to further assist clinicians in providing care.

The patient summary feature will allow doctors to access essential patient information, such as age, medical history, chronic conditions, and recent prescriptions, with a single click. By consolidating this information in one place, the feature aims to save clinicians the 15 to 30 minutes they typically spend searching for these details. Additionally, Suki’s new Q&A tool will allow doctors to ask specific questions about a patient’s health, such as querying their latest lab results or vaccination history. This tool uses AI to provide quick, accurate answers, improving efficiency and enabling healthcare providers to focus more on patient care.

The new features are expected to be available to a select group of clinicians starting today, with general availability anticipated for early next year. Importantly, these updates will not incur additional costs for existing customers.

Suki’s CEO, Punit Soni, emphasized that the company’s vision has always been to create a comprehensive assistant for clinicians, not just a documentation tool. He added that Suki’s innovations reflect a broader trend in healthcare, where AI is increasingly being integrated into clinical workflows to reduce administrative burdens. Soni, who previously worked at Google, stated that AI’s role in healthcare is poised for significant growth, much like the internet’s transformative impact on business and communication.

The company, which is already used by 350 health systems and clinics across the U.S., has seen rapid growth, tripling its client base this year. As healthcare systems continue to face challenges related to burnout and administrative overload, AI tools like Suki’s could become essential in easing the workload for doctors and improving overall efficiency in the healthcare sector.

Suki recently raised $70 million in funding, highlighting the growing interest from investors in healthcare AI solutions. With competition intensifying, including from companies like Microsoft’s Nuance Communications, which also provides AI-powered documentation tools, Suki’s ability to innovate with these new features will be crucial in maintaining its competitive edge.